Prices for a 40-year-old cancer drug called lomustine have skyrocketed nearly 1,400 percent since 2013. The Wall Street Journal reports the price hike came after a company called NextSource acquired the drug. Source
Prices for a 40-year-old cancer drug called lomustine have skyrocketed nearly 1,400 percent since 2013. The Wall Street Journal reports the price hike came after a company called NextSource acquired the drug. Source